Concepedia

Michael S. Huie

MS

Statistics

Publications

6

Citations

271

H-Index

6

Active since

2005

Affiliations

University of Wisconsin–Madison(Current)

University of Wisconsin Carbone Cancer Center

Aspirus Wausau Hospital

University of Wisconsin–Green Bay

Regional Cancer Center

Michael S. Huie is an author at University of Wisconsin–Madison specializing in oncology, medicine, and chemotherapy.

Publications per year

2005–2017

6

Publications

6

Vorinostat (NSC# 701852) in Patients with Relapsed Non-small Cell Lung Cancer: A Wisconsin Oncology Network Phase II Study

Anne M. Traynor, Sarita Dubey, Jens C. Eickhoff et al. · Journal of Thoracic Oncology · 2009 · 139 citations · Full text

Medicine, Oncology, Pharmacotherapy +9

VcR‐CVAD induction chemotherapy followed by maintenance rituximab in mantle cell lymphoma: a Wisconsin Oncology Network study

Christopher G. Peterson, Sangbum Choi, Jens C. Eickhoff et al. · British Journal of Haematology · 2011 · 51 citations · Full text

Medicine, Oncology, Pharmacotherapy +12

Vorinostat and bortezomib as third-line therapy in patients with advanced non-small cell lung cancer: a Wisconsin Oncology Network Phase II study

Tien Hoang, Toby C. Campbell, Chong Zhang et al. · Investigational New Drugs · 2013 · 37 citations · Full text

Medicine, Oncology, Pharmacotherapy +14

VcR-CVAD Produces a High Complete Response Rate in Untreated Mantle Cell Lymphoma: A Phase II Study from the Wisconsin Oncology Network

Brad S. Kahl, Julie Chang, Jens C. Eickhoff et al. · Blood · 2008 · 19 citations

Medicine, Biomedical Sciences, Oncology +12

VcR-CVAD Induction Chemotherapy Followed by Maintenance Rituximab Produces Durable Remissions in Mantle Cell Lymphoma: A Wisconsin Oncology Network Study

Lakeesha Carmichael, KyungMann Kim, Christopher G. Peterson et al. · Clinical Lymphoma Myeloma & Leukemia · 2017 · 15 citations · Full text

Medicine, Oncology, Pharmacotherapy +11

1–5 of 6